Study of the Intravitreal Implantation of NT-503-3 Encapsulated Cell Technology (ECT) for the Treatment of Recurrent Choroidal Neovascularization (CNV) Secondary to Age-related Macular Degeneration (AMD)

Mid Atlantic Retina, Philadelphia

The Retina Group of Washington, Chevy Chase

Cumberland Valley Retina Consultants, PC, Hagerstown

Wake Forest Baptist Health Eye Center, Winston-Salem

Western Carolina Retinal Associates, Asheville

Palmetto Retina Center, LLC, Florence

Georgina Retina, P.C., Marietta

Southeast Retina Center, PC, Augusta

Center for Retina and Macular Disease, Winter Haven

Retina Health Center, Fort Myers

National Ophthalmic Research Institute, Fort Myers

Retina Associates of Kentucky, Lexington

Cleveland Clinic, Cleveland

Meir Medical Center, Kfar Saba

William Beaumont Hospital-Ophthalmology Research, Royal Oak

University of Michigan, Kellogg Eye Center, Ann Arbor

Rabin Medical Center, Petah Tikva

Medical College of Wisconsin, Milwaukee

Black Hills Regional Eye Institute, Rapid City

Illinois Retina Associates, Oak Park

Illinois Retina Associates, S.C., Joliet

Lifelong Vision Foundation, Chesterfield

Sourasky Medical Center,, Tel Aviv

Kaplan Medical Center, Rehovot

Medical Center Ophthalmology Associates, San Antonio

Valley Retina Institute, PA, McAllen

Colorado Retina Associates, Golden

Associated Retina Consultants, Ltd., Phoenix

Sierra Eye Associates, Reno

Retina-Vitreous Associates Medical Group, Beverly Hills

Hadassah-Hebrew University Medical Center, Jerusalem

Jacobs Retina Center at UCSD, La Jolla

University of California, Irvine, The Gavin Herbert Eye Institute, Irvine

Retina Northwest, PC, Portland

Ophthalmic Consultants of Boston, Boston

Retina Center of New Jersey, LLC, Bloomfield

NJ Retina, New Brunswick

Soroka Medical Center, Beersheba